Partners

Partners for biotech venture creation and activation.

WBV collaborates with selected partners who bring tangible capabilities across investment, incubation, scientific evaluation, company creation, business development, licensing, commercialization, and strategic transactions.

Team

The team driving venture creation and biotech development.

Our team combines scientific, operational, investment, and strategic expertise to support the identification, formation, and advancement of biotechnology opportunities.

Managing Partner

Guanghui Hu

Dr. Guanghui Hu is a serial entrepreneur and a venture investor in the biotech and healthcare industry. He was honored with the EY Entrepreneur of The Year award for his achievements in business and leadership. He also acquired rich experience in drug discovery and development at leading biopharma companies. Dr. Hu is currently a Founding Partner of Westfield BioVentures, Venture Partner of Viva BioInnovator, and a CEO/Board Director/Advisor of many startups. He holds a PhD from Baylor College of Medicine and a BS from Tsinghua University.

Partner

Timur Yusufzai

Timur initially trained as a biochemist and has since contributed to the development and discovery of new therapeutics in various settings, including academia, venture capital, and biotech startups. He previously held faculty positions at Harvard Medical School and the Dana-Farber Cancer Institute, where he collaborated closely with Novartis Oncology. Timur then joined Third Rock Ventures as an EIR, playing a pivotal role in incubating multiple startups. Subsequently, he founded MOMA Therapeutics, where he established the company’s initial platform and discovery programs. Later, Timur launched his second startup, Episode One Labs, which specializes in delivering high-quality, domestic CRO services, catering specifically to early-stage and stealth startups. In addition, he continues to provide strategic guidance and fundraising advice to multiple startups.

Selective Collaboration

Execution-focused partnerships across venture creation and biotech development.

Our partner model is focused on execution, not broad affiliation. WBV works selectively with organizations that can contribute meaningful capabilities, strategic coordination, and operational value across biotech therapeutics opportunities.

Strategic Partner

Viva BioInnovator

Viva BioInnovator is an investment and incubation partner supporting early-stage biotech company development, venture formation, and innovation acceleration.

Strategic Partner

Protheragen

Protheragen is a biotech innovation and development partner supporting early-stage company development, translational execution, and venture-building activities.

Strategic Partner

Admera Health

Admera Health brings precision medicine, genomic, and molecular capabilities that may support biomarker-driven biotech development and translational strategy.

Strategic Partner

Embark Ventures

Embark Ventures is an early-stage investment and venture-building partner, supporting selected biotech opportunities through pre-seed/seed investor perspective, capital formation, syndicate participation, and NewCo-building support.

Strategic Partner

Axara Advisors

Axara Advisors is a company-building, scientific and technical evaluation, business development, licensing, and strategic partnering partner.

Strategic Partner

Discovery Blueprint

Discovery Blueprint is a discovery strategy and buildability partner, helping assess whether promising IP and early biology are truly buildable and defining the assay architecture, decision framework, and execution plan needed to move them forward.

Interested in partnering on biotech venture creation, incubation, investment, or activation?

WBV works selectively with aligned organizations capable of contributing meaningful scientific, strategic, operational, or investment value.